Trade-offs in cervical cancer prevention: balancing benefits and risks.
about
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen.Validation of human papillomavirus genotyping by signature DNA sequence analysis.Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparitiesClinical significance of HPV-DNA testing for precancerous cervical lesionsCervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.Improving compliance with cervical cancer screening guidelines.Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infectionScreening adolescents and young womenUpdates of the current screening guidelines for the early detection of cervical cancer.Making Sense of Cervical Cancer Screening Guidelines and Recommendations.High lifetime probability of screen-detected cervical abnormalities.Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway.HPV infection among women in a representative rural and suburban population of the USA.American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
P2860
Q24607403-B591B231-1307-4E6D-9582-C477AF90EC6EQ26828840-D01195F0-88C9-4A45-9103-5462C7AA0377Q33428795-37D7700D-5733-4AAF-8549-E9B1263ED357Q33450984-9A0CEEB6-1872-4517-ACA7-C0E4D16A996EQ34064401-A0E060B4-FA5F-4FFF-B078-73EB8069D04AQ34774870-8CF36BDA-F517-4817-A655-5CA323D07FCEQ35223397-AE44F00A-76BB-4F92-92CC-D8244F0A633BQ35340725-F3E364A6-1AFA-4382-A554-D41E6841B6BBQ35985606-D02C5978-A53B-414D-87DD-BE3726C2DC92Q36058295-9BEC6C92-F7F9-44FC-ADC1-B385A28FBE0FQ36530640-B10E9AC4-7650-4668-A2E0-1EC19E98D5C7Q36567658-207E8B55-C7AE-4AEB-9C45-3BDE0D3C0B44Q36903551-76897B16-E738-44B4-8DEF-1DACE58BB02FQ37022503-C2701D44-AF5A-4EC0-A999-C81DF35D8100Q38607427-46601A9F-78B7-41C2-B737-A4E8DFA8BC74Q39028825-7E75E071-FFCC-4BE3-824C-0869DE65BF2CQ40096086-85F7DFCC-D0F8-4A82-9701-DE618AA0BC5DQ51653476-234A871D-4653-4C21-A39B-821AF2643DEBQ57089342-225D26A1-74AC-4E0C-9B7E-9B0503E67683
P2860
Trade-offs in cervical cancer prevention: balancing benefits and risks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@en
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@nl
type
label
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@en
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@nl
prefLabel
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@en
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@nl
P2860
P1476
Trade-offs in cervical cancer prevention: balancing benefits and risks.
@en
P2093
Jesse D Ortendahl
Natasha K Stout
P2860
P304
P356
10.1001/ARCHINTE.168.17.1881
P407
P577
2008-09-01T00:00:00Z